Unknown PHASE4 INTERVENTIONAL 4-arm NCT04759196

Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas (GENESIS)

Sponsor: Université de Sherbrooke

Conditions Chronic Subdural Hematoma Cortical Depression; Cortical Depolarization Epilepsy; Seizure NESIS Nonepileptic, Stereotypical and Intermittent Symptoms

Interventions Levetiracetam Topamax

Updated 5 times since 2021 Last updated: Apr 27, 2021 Started: Mar 1, 2021 Primary completion: Sep 30, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04759196, this PHASE4 trial focuses on Chronic Subdural Hematoma and Cortical Depression; Cortical Depolarization and remains ongoing. Sponsored by Université de Sherbrooke, it has been updated 5 times since 2021, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
May 2021 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Mar 2021 — May 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Université de Sherbrooke

Data source: Université de Sherbrooke

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sherbrooke, Canada